Evidence map›Paper›PMID 33176455›Full record

ReviewCirculation. Heart failure2020

Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document.

Enrico Ammirati, Maria Frigerio, Eric D Adler, Cristina Basso, David H Birnie, Michela Brambatti, Matthias G Friedrich, Karin Klingel, Jukka Lehtonen, Javid J Moslehi and 6 more

7 registry-linked trialsOpen access · bronzeAbstract readReviewVideo-Audio MediaConsensus Statement
In one paragraph

Review in Circulation. Heart failure, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 7 registered trials, which are not on this map. Cited by 426 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
426citing papers in PubMed, 4 pooled it
52.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05150704 phase3recruitingnot on this mapstarted 2021, after this paper: background citation

Single Blind Randomized Controlled Trial to Assess the Safety and Efficacy of High Dose Pulse Intravenous Corticosteroid Therapy to Treat Patients With Complicated/Fulminant Acute Myocarditis

TypeinterventionalSponsorNiguarda HospitalRan2021 to 2028Enrolled288ConditionsMyocarditis AcuteArmsMethylprednisolone, saline solution
NCT05949450 not yet recruitingnot on this mapstarted 2023, after this paper: background citation

Prognostic Role of Troponin Dosed at 3 to 6 Months in the Evolution of Acute Myocarditis

TypeobservationalSponsorUniversity Hospital, GrenobleRan2023 to 2030Enrolled244ConditionsMyocarditis
NCT05961202 phase2 / phase3recruitingnot on this mapstarted 2021, after this paper: background citation

The Efficacy and Mechanism of Hydroxychloroquine in Patients with Inflammatory Cardiomyopathy After Myocarditis

TypeinterventionalSponsorTongji HospitalRan2021 to 2025Enrolled200ConditionsInflammatory Cardiomyopathy, MyocarditisArmsHydroxychloroquine, Prednisolone
NCT05974462 phase3recruitingnot on this mapstarted 2024, after this paper: background citation

Single-blind, Investigator-initiated, Randomized, Controlled Trial to Assess the Safety and Efficacy of Intravenous Corticosteroid Therapy to Treat Patients With Acute Myocarditis With Mildly Reduced Left Ventricular Ejection Fraction

TypeinterventionalSponsorUniversity Hospital, AntwerpRan2024 to 2028Enrolled174ConditionsAcute MyocarditisArmsMethylprednisolone 125 MG, IV saline solution 0.9%
NCT06158698 phase3recruitingnot on this mapstarted 2023, after this paper: background citation

Single-blinded Randomized Investigator-initiated Controlled Trial to Assess the Efficacy of Colchicine to Treat Patients With Cardiomyopathy With Myocarditis (Chronic Inflammatory Cardiomyopathy)

TypeinterventionalSponsorNiguarda HospitalRan2023 to 2028Enrolled80ConditionsCardiomyopathies, Myocarditis, Inflammatory Cardiomyopathy, Heart FailureArmsColchicine, Placebo
NCT07086144 narecruitingnot on this mapstarted 2024, after this paper: background citation

Efficacy of a Myocardial Panel (Virological, Bacterial and Autoimmune) in the Management and Treatment of Pediatric Myocarditis Complicated With Arrhythmias or Ventricular Dysfunction

TypeinterventionalSponsorAzienda Ospedaliero, Universitaria Ospedali RiunitiRan2024 to 2028Enrolled30ConditionsMyocarditisArmsDetermination of viral genome, bacterial serology, and markers of inflammation in pediatrics diagnosed with myocarditis
NCT07175948 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Outcome of Different Clinical Phenotypes of Myocarditis in Children Admitted to Assiut University Children Hospital

TypeobservationalSponsorAssiut UniversityRan2026 to 2027Enrolled100ConditionsMyocarditis, Myocarditis AcuteArmsStandard Medical Therapy
3 · Its place in the literature

Who cites it

426 citing papers in PubMed, 4 syntheses or guidelines pooled it, 746 citations in OpenAlex.

  1. Incidence and predictors of major arrhythmic events after myocarditis: a systematic review and meta-analysis.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Clinical characteristics associated with sustained ventricular arrhythmia among acute myocarditis patients: a multicenter case-control study.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Article
  17. Review
  18. Article
  19. Review
  20. Post-viral myocarditis.Heart failure reviews · 2026
    Review

366 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 14 institutions in 5 countries.

Enrico Ammirati *De Gasperis Cardio Center and Transplant Center, Niguarda Hospital, Milano, Italy (E.A., M.F., P.P.).
Maria Frigerio *De Gasperis Cardio Center and Transplant Center, Niguarda Hospital, Milano, Italy (E.A., M.F., P.P.).
Eric D AdlerDivision of Cardiology, Department of Medicine, University of California San Diego, La Jolla (E.D.A., M.B.).
Cristina BassoCardiovascular Pathology, Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padova, Italy (C.B.).
David H BirnieUniversity of Ottawa Heart Institute, Ontario, Canada (D.H.B.).
Michela BrambattiDivision of Cardiology, Department of Medicine, University of California San Diego, La Jolla (E.D.A., M.B.).
Matthias G FriedrichDepartment of Medicine and Diagnostic Radiology, McGill University, Montreal, Quebec, Canada (M.G.F.).
Karin KlingelCardiopathology, Institute for Pathology and Neuropathology, University Hospital Tübingen, Germany (K.K.).
Jukka LehtonenHeart and Lung Center, Helsinki University Hospital, Finland (J.L.).
Javid J MoslehiCardio-Oncology Program, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (J.J.M.).
Patrizia PedrottiDe Gasperis Cardio Center and Transplant Center, Niguarda Hospital, Milano, Italy (E.A., M.F., P.P.).
Ornella E RimoldiIBFM CNR, Segrate, Italy (O.E.R.).
Heinz-Peter SchultheissInstitute for Cardiac Diagnostics and Therapy, Berlin, Germany (H.-P.S.).
Carsten TschöpeInstitute of Health Center for Regenerative Therapies (BCRT), Charité, University Medicine Berlin, Campus Virchow Clinic, Berlin, Germany (C.T.).
Leslie T Cooper *Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL (L.T.C.).
Paolo G Camici *Vita Salute University and San Raffaele Hospital, Milano, Italy (P.G.C.).
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITVita-Salute San Raffaele University · ITBerlin-Brandenburger Centrum für Regenerative Therapien · DECS Diagnostics · DEHelsinki University Hospital · FIInstitute of Molecular Bioimaging and Physiology · ITIonis Pharmaceuticals (United States) · USJacksonville College · USMcGill University · CAUniversity of California San Diego · USUniversity of Ottawa · CAUniversity of Padua · ITUniversity of Tübingen · DEVanderbilt University Medical Center · US

Funding

Novel mechanisms and predictors of VEGF receptor inhibitor-associated hypertensionR01HL141466 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MOSLEHI, JAVID J · 2019 to 2023
$3.3M
Long-Term Cardiovascular Sequelae of Cancer ImmunotherapiesR01HL155990 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI JOHNSON, DOUGLAS B, MOSLEHI, JAVID J · 2021 to 2025
$3.3M
NHLBI NIH HHS R01 HL141466NHLBI NIH HHS R01 HL155990
6 · The paper itself

Abstract

Myocarditis is an inflammatory disease of the heart that may occur because of infections, immune system activation, or exposure to drugs. The diagnosis of myocarditis has changed due to the introduction of cardiac magnetic resonance imaging. We present an expert consensus document aimed to summarize the common terminology related to myocarditis meanwhile highlighting some areas of controversies and uncertainties and the unmet clinical needs. In fact, controversies persist regarding mechanisms that determine the transition from the initial trigger to myocardial inflammation and from acute myocardial damage to chronic ventricular dysfunction. It is still uncertain which viruses (besides enteroviruses) cause direct tissue damage, act as triggers for immune-mediated damage, or both. Regarding terminology, myocarditis can be characterized according to etiology, phase, and severity of the disease, predominant symptoms, and pathological findings. Clinically, acute myocarditis (AM) implies a short time elapsed from the onset of symptoms and diagnosis (generally <1 month). In contrast, chronic inflammatory cardiomyopathy indicates myocardial inflammation with established dilated cardiomyopathy or hypokinetic nondilated phenotype, which in the advanced stages evolves into fibrosis without detectable inflammation. Suggested diagnostic and treatment recommendations for AM and chronic inflammatory cardiomyopathy are mainly based on expert opinion given the lack of well-designed contemporary clinical studies in the field. We will provide a shared and practical approach to patient diagnosis and management, underlying differences between the European and US scientific statements on this topic. We explain the role of histology that defines subtypes of myocarditis and its prognostic and therapeutic implications.

Indexed as

Acute DiseaseCardiologyChronic DiseaseConsensusHumansMyocarditisPredictive Value of TestsRisk FactorsTerminology as TopicTreatment Outcomecardiac magnetic resonance imagingendomyocardial biopsyinflammatory cardiomyopathymyocarditisviruses

Identifiers

PMID33176455
PMCPMC7673642
OpenAlexW3103940138

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

and 1 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.